vs
ASP Isotopes Inc.（ASPI）与C4 Therapeutics, Inc.（CCCC）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是C4 Therapeutics, Inc.的1.5倍（$16.7M vs $11.0M），ASP Isotopes Inc.同比增速更快（1295.7% vs 112.8%）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
C4 Therapeutics是一家临床阶段生物制药企业，专注于开发靶向蛋白降解疗法，用于治疗癌症及其他存在重大未满足医疗需求的严重疾病。公司依托自有专利TORPEDO平台设计小分子降解剂清除致病蛋白，目前拥有多条肿瘤领域研发管线，并与头部制药企业达成战略合作。
ASPI vs CCCC — 直观对比
营收规模更大
ASPI
是对方的1.5倍
$11.0M
营收增速更快
ASPI
高出1182.9%
112.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $11.0M |
| 净利润 | — | $-20.5M |
| 毛利率 | 12.5% | — |
| 营业利润率 | — | -210.1% |
| 净利率 | — | -186.0% |
| 营收同比 | 1295.7% | 112.8% |
| 净利润同比 | -586.8% | 40.7% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPICCCC
| Q4 25 | $16.7M | $11.0M | ||
| Q3 25 | $4.9M | $11.2M | ||
| Q2 25 | — | $6.5M | ||
| Q1 25 | — | $7.2M | ||
| Q4 24 | — | $5.2M | ||
| Q3 24 | — | $15.4M | ||
| Q2 24 | — | $12.0M | ||
| Q1 24 | — | $3.0M |
净利润ASPICCCC
| Q4 25 | — | $-20.5M | ||
| Q3 25 | $-12.9M | $-32.2M | ||
| Q2 25 | — | $-26.0M | ||
| Q1 25 | — | $-26.3M | ||
| Q4 24 | — | $-34.6M | ||
| Q3 24 | — | $-24.7M | ||
| Q2 24 | — | $-17.7M | ||
| Q1 24 | — | $-28.4M |
毛利率ASPICCCC
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ASPICCCC
| Q4 25 | — | -210.1% | ||
| Q3 25 | -306.1% | -306.4% | ||
| Q2 25 | — | -441.0% | ||
| Q1 25 | — | -402.9% | ||
| Q4 24 | — | -728.4% | ||
| Q3 24 | — | -183.9% | ||
| Q2 24 | — | -178.6% | ||
| Q1 24 | — | -1060.2% |
净利率ASPICCCC
| Q4 25 | — | -186.0% | ||
| Q3 25 | -263.7% | -286.4% | ||
| Q2 25 | — | -402.6% | ||
| Q1 25 | — | -363.7% | ||
| Q4 24 | — | -667.8% | ||
| Q3 24 | — | -160.6% | ||
| Q2 24 | — | -147.6% | ||
| Q1 24 | — | -933.2% |
每股收益（稀释后）ASPICCCC
| Q4 25 | — | $-0.09 | ||
| Q3 25 | $-0.15 | $-0.44 | ||
| Q2 25 | — | $-0.37 | ||
| Q1 25 | — | $-0.37 | ||
| Q4 24 | — | $-0.50 | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $74.6M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $256.6M |
| 总资产 | $498.0M | $359.1M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPICCCC
| Q4 25 | $333.3M | $74.6M | ||
| Q3 25 | $113.9M | $58.8M | ||
| Q2 25 | — | $78.2M | ||
| Q1 25 | — | $51.3M | ||
| Q4 24 | — | $55.5M | ||
| Q3 24 | — | $59.6M | ||
| Q2 24 | — | $73.1M | ||
| Q1 24 | — | $89.7M |
总债务ASPICCCC
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASPICCCC
| Q4 25 | $204.2M | $256.6M | ||
| Q3 25 | $74.1M | $154.4M | ||
| Q2 25 | — | $174.1M | ||
| Q1 25 | — | $195.1M | ||
| Q4 24 | — | $216.0M | ||
| Q3 24 | — | $242.7M | ||
| Q2 24 | — | $247.1M | ||
| Q1 24 | — | $258.3M |
总资产ASPICCCC
| Q4 25 | $498.0M | $359.1M | ||
| Q3 25 | $225.9M | $265.5M | ||
| Q2 25 | — | $296.5M | ||
| Q1 25 | — | $319.5M | ||
| Q4 24 | — | $349.6M | ||
| Q3 24 | — | $376.1M | ||
| Q2 24 | — | $381.1M | ||
| Q1 24 | — | $398.4M |
负债/权益比ASPICCCC
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $-22.1M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | — |
| 自由现金流率自由现金流/营收 | -284.7% | — |
| 资本支出强度资本支出/营收 | 57.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASPICCCC
| Q4 25 | $-37.8M | $-22.1M | ||
| Q3 25 | $-8.9M | $-31.2M | ||
| Q2 25 | — | $-12.1M | ||
| Q1 25 | — | $-33.3M | ||
| Q4 24 | — | $-17.9M | ||
| Q3 24 | — | $-24.1M | ||
| Q2 24 | — | $-5.0M | ||
| Q1 24 | — | $-18.1M |
自由现金流ASPICCCC
| Q4 25 | $-47.4M | — | ||
| Q3 25 | $-12.0M | $-31.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-17.9M | ||
| Q3 24 | — | $-24.1M | ||
| Q2 24 | — | $-5.2M | ||
| Q1 24 | — | — |
自由现金流率ASPICCCC
| Q4 25 | -284.7% | — | ||
| Q3 25 | -245.5% | -281.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -346.5% | ||
| Q3 24 | — | -157.2% | ||
| Q2 24 | — | -43.1% | ||
| Q1 24 | — | — |
资本支出强度ASPICCCC
| Q4 25 | 57.9% | — | ||
| Q3 25 | 64.4% | 3.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
